AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10714612
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg diclofenac‐Na effervescent (fast-release NSAID)
Trial: 10714612
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg diclofenac tablets (control)
Trial: 8854192
Drug: Protocol 5:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol 5: biphasic injection of 100 mL of iohexol 300 (g/100 mL) at a flow rate of 1.5 mL/second followed by 25 mL at 2 mL/second; total iodine load = 37.5 g, with a scan delay of 70 seconds
Trial: 30577864
Drug: Granulocyte colony
RxNorm normalized name: Granulocyte colony stimulating factor
DrugBank: Filgrastim (DB00099)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Granulocyte colony stimulating factor (G‐CSF) treatment (5 μg/kg/day for 5 days followed by every 3 days) in patients with partial response (PR) to corticosteroids.
Trial: 30577864
Drug: Granulocyte colony
RxNorm normalized name: Granulocyte colony stimulating factor
DrugBank: Filgrastim (DB00099)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Granulocyte colony stimulating factor (G‐CSF) treatment in patients with null response (NR) to corticosteroids.
Trial: 30577864
Drug: Prednisolone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (40 mg/day for 1 week) followed by 28 days of treatment and tapering for an additional 2 weeks in patients with partial response (PR).
Trial: 18301879
Drug: Pre-operative heparin
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-operative heparin infusion
Trial: 12079501
Drug: Enzyme replacement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enzyme replacement therapy (administered by intravenous infusion every two weeks for 6 months)
Trial: 10418756
Drug: Ceftriaxone 1
RxNorm normalized name: ceftriaxone 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone 1 g once daily (CTX)
Trial: 7740639
Drug: Citalopram (10-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (10-40 mg/day) for three and six weeks
Trial: 7740639
Drug: Citalopram (10-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (10-40 mg/day)
Trial: 27697302
Drug: EP-1300 polyepitope
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EP-1300 polyepitope DNA vaccine administered via electroporation
Trial: 25071414
Drug: Structured oral
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured oral information in addition to standard care, covering procedural, sensory, and coping information, and individualized fears and questions; administered in a single episode lasting 10-15 minutes.
Trial: 25071414
Drug: Non-specific episodic
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-specific episodic conversation of similar length in addition to standard care; administered in a single episode lasting 10-15 minutes.
Trial: 17370153
Drug: Optimal drug
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal drug therapy for heart failure
Trial: 15730636
Drug: Oseltamivir 75
RxNorm normalized name: oseltamivir 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oseltamivir 75 mg, twice daily for 5 days
Trial: 15730636
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (symptom relief medicine)
Trial: 11777221
Drug: Clariscan 0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clariscan 0.75 mg Fe/kg body weight
Trial: 11777221
Drug: Clariscan 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clariscan 2 mg Fe/kg body weight
Trial: 11777221
Drug: Clariscan 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clariscan 5 mg Fe/kg body weight
Trial: 9133758
Drug: Sertraline (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (n = 56)
Trial: 29868853
Drug: Verinurad combined
RxNorm normalized name: Verinurad
DrugBank: Verinurad (DB11873)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verinurad combined with febuxostat (2.5-10 mg with febuxostat 10, 20, 40 mg)
Trial: 29868853
Drug: Verinurad alone
RxNorm normalized name: Verinurad
DrugBank: Verinurad (DB11873)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verinurad alone (2.5-15 mg)
Trial: 29868853
Drug: Febuxostat alone
RxNorm normalized name: Febuxostat
DrugBank: Febuxostat (DB04854)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Febuxostat alone (10, 20, 40 mg)
Trial: 29868853
Drug: Benzbromarone alone
RxNorm normalized name: benzbromarone
DrugBank: Benzbromarone (DB12319)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzbromarone alone (50 mg)
Trial: 25338798
Drug: Periodontal-pulp combined
RxNorm normalized name: acai fruit pulp
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periodontal-pulp combined therapy
Trial: 25338798
Drug: Periodontal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periodontal therapy (Control)
Trial: 27893539
Drug: Radiofrequency (RF)
RxNorm normalized name: Aminosyn-RF 5.2 %, Sulfite-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiofrequency (RF) treatment
Trial: 15389228
Drug: Intravenous N-acetylcysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous N-acetylcysteine (NAC) 500 mg immediately before the procedure
Trial: 7925519
Drug: Nifedipine CC
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine CC (40 mg oral dose)
Trial: 63748
Drug: sulphafurazole (sulfisoxazole),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sulphafurazole (sulfisoxazole), 500 mg orally q.i.d. for 10 days
Trial: 63748
Drug: aminocyclitols (streptomycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aminocyclitols (streptomycin or spectinomycin), 2 g intramuscularly for 1 to 3 doses at 12 h intervals
Trial: 63748
Drug: C+U+ N.G.U.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C+U+ N.G.U.
Trial: 30661559
Drug: Naturalistic cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naturalistic cognitive behavioral therapy (CBT)
Trial: 23568940
Drug: Trust in
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trust in vaccine safety
Trial: 19828711
Drug: Iron-fortified milk
RxNorm normalized name: iron succinyl milk protein complex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron-fortified milk (1.5 mg iron/100 g prepared milk)
Trial: 19828711
Drug: Red meat
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red meat (approximately 2.6 mg iron from red meat dishes daily)
Trial: 19828711
Drug: Control (nonfortified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (nonfortified milk with 0.01 mg iron/100 g prepared milk)
Trial: 10423226
Drug: Brand N
RxNorm normalized name: Select Brand Naproxen Sodium 220mg Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brand N (RMP + INH tablet)
Trial: 10423226
Drug: Brand R
RxNorm normalized name: von Willebrand receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brand R (reference brand R, RMP + INH tablet)
Trial: 10423226
Drug: Brand L
RxNorm normalized name: Select Brand Lancets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brand L (RMP + INH capsule)
Trial: 92091
Drug: Megestrol (Megace,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Megestrol (Megace, 120 mg./day)
Trial: 23471856
Drug: Subcutaneous skin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous skin elevation
Trial: 19124628
Drug: Vitamin B12
RxNorm normalized name: Vitamin B12
DrugBank: Cyanocobalamin Co-57 (DB09385)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin B12 (1000 mcg sublingual) for 6 months
Trial: 15151491
Drug: Individualised supervised
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualised supervised physiotherapy treatment
Trial: 15151491
Drug: Individualised physiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualised physiotherapy treatment
Trial: 11481625
Drug: peginterferon alfa-2b
RxNorm normalized name: Peginterferon alfa-2b
DrugBank: Peginterferon alfa-2b (DB00022)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: peginterferon alfa-2b (0.5, 1.0, or 1.5 microg/kg, once-weekly)
Trial: 11481625
Drug: peginterferon alfa-2b
RxNorm normalized name: Peginterferon alfa-2b
DrugBank: Peginterferon alfa-2b (DB00022)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: peginterferon alfa-2b (all doses)
Trial: 11481625
Drug: interferon alfa-2b
RxNorm normalized name: Interferon Alfa-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: interferon alfa-2b (3 MIU, three-times-weekly)
Trial: 9494998
Drug: Intravesical installation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical installation of 30 mg capsaicin in 100 ml of 30% alcohol
Trial: 9494998
Drug: 100 ml
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 ml 30% alcohol alone (control group)
Trial: 31329189
Drug: Complex non-drug
RxNorm normalized name: hesperidin complex
DrugBank: Citrus bioflavonoids (DB14586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complex non-drug programs including exercise therapy, mineral water, multivitamins, minerals, and physiotherapy (vibrotherapy, chromotherapy, melotherapy, aromatherapy, aeroionotherapy)
Trial: 31329189
Drug: Complex non-drug
RxNorm normalized name: hesperidin complex
DrugBank: Citrus bioflavonoids (DB14586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complex non-drug programs including vibrotherapy, chromotherapy, melotherapy, aromatherapy, and aeroionotherapy
Trial: 19796594
Drug: Bristled brush
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bristled brush pre-treatment
Trial: 16839845
Drug: ACTH1-24 1
RxNorm normalized name: ACTH
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ACTH1-24 1 mg IM, daily for 4 days
Trial: 16839845
Drug: Cortisol 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol 150 mg ID (50 mg tid) daily for 4 days
Trial: 15486187
Drug: Doxorubicin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin (75 mg/m² q3wks)
Trial: 15486187
Drug: Docetaxel (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (100 mg/m² q3wks)
Trial: 7680995
Drug: 2.9 g
RxNorm normalized name: ZINC OXIDE 12.9 g in 100 g TOPICAL LOTION [UV Skin Recovery SPF 50]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.9 g piracetam
Trial: 7680995
Drug: 4.8 g
RxNorm normalized name: ALCOHOL 74.8 g in 100 g TOPICAL SWAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.8 g piracetam
Trial: 7680995
Drug: 9.6 g
RxNorm normalized name: PETROLATUM 99.6 g in 100 g TOPICAL JELLY [Petrolatum Jelly]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9.6 g piracetam
Trial: 25182161
Drug: Diastolic blood
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diastolic blood pressure lowering treatment
Trial: 18543037
Drug: Perioperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative chemotherapy with Epidoxorubicin, Etoposide, and Cisplatin (EEP)
Trial: 18543037
Drug: Surgery with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery with postoperative chemotherapy alone (previously studied controls)
Trial: 12744488
Drug: 20 mg/day
RxNorm normalized name: futibatinib 20 mg/day (4 mg x 5) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/day enalapril for 5 days
Trial: 12744488
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 20 mg enalapril 2 h before LPS infusion
Trial: 11223318
Drug: Effective treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Effective treatment included in trial protocol
Trial: 9551704
Drug: Valsartan alone
RxNorm normalized name: Valsartan
DrugBank: Valsartan (DB00177)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Valsartan alone (160 mg)
Trial: 9551704
Drug: Cimetidine alone
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine alone (800 mg)
Trial: 29065953
Drug: Lemborexant (1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lemborexant (1, 2.5, 5, 10, 15, 25 mg)
Trial: 29065953
Drug: Lemborexant (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lemborexant (doses > 1 mg)
Trial: 29065953
Drug: Lemborexant (2.5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lemborexant (2.5-10 mg)
Trial: 25495490
Drug: Tamoxifen plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen plus ovarian suppression (in patients who received prior chemotherapy)
Trial: 25495490
Drug: Tamoxifen (in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (in patients who received prior chemotherapy)
Trial: 16489082
Drug: Concurrent docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent docetaxel plus vaccine
Trial: 9148018
Drug: Vaccine alone
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine alone
Trial: 11202309
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment with multimodal therapy including chemotherapy
Trial: 7918155
Drug: rhSOD (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhSOD (200 mg intravenously during surgery)
Trial: 29457429
Drug: Stiletto needle
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stiletto needle treatment once a week for 2 weeks
Trial: 29457429
Drug: Needle-knife treatment
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needle-knife treatment once a week for 2 weeks
Trial: 29457429
Drug: Voltaren treatment
RxNorm normalized name: Voltarene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voltaren treatment (votalin emulsion smearing 3 to 5 cm on painful area of knee joint, three times a day for 2 weeks)
Trial: 21490326
Drug: Intravenous fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous fat emulsion
Trial: 12883232
Drug: Itraconazole 100
RxNorm normalized name: itraconazole 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 100 mg/d for 14 days
Trial: 10868320
Drug: ECT x
RxNorm normalized name: BRIEF,SELECT XX-LARGE #2608
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ECT x 2 (twice weekly)
Trial: 10868320
Drug: ECT x
RxNorm normalized name: BRIEF,SELECT XX-LARGE #2608
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ECT x 3 (three times weekly)
Trial: 2870753
Drug: Active neuroleptic
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active neuroleptic medication
Trial: 23364781
Drug: Caudal block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal block with 1 mL kg(‐1) 0.25% levobupivacaine
Trial: 14966922
Drug: Erythropoietin (20,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin (20,000 IU Epoetin alfa subcutaneously on days 0, 4, and 6) plus iron (100 mg im on days 1-6)
Trial: 11347747
Drug: L-arginine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (3 g three times per day)
Trial: 2889679
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg cinolazepam
Trial: 30671869
Drug: Brexpiprazole 2–4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brexpiprazole 2–4 mg/day
Trial: 30671869
Drug: Brexpiprazole 1–4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brexpiprazole 1–4 mg/day (maintenance treatment)
Trial: 28494892
Drug: Continuous TAP
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous TAP block using ultrasound-guidance with 0.2% ropivacaine at a basal rate of 3mL/h, bolus dose of 4mL, and a lockout interval of 30min for 48h postoperatively
Trial: 24458265
Drug: Cold water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold water immersion therapy
Trial: 24458265
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no cold water immersion therapy)
Trial: 16972117
Drug: Methylphenidate combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate combined with 10 weeks of multimodal behavior therapy
Trial: 12660880
Drug: Thiazolidinedione treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiazolidinedione treatment
Trial: 2149281
Drug: Toremifene (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toremifene (oral doses of 10-480 mg per day for one or five days)
Trial: 30058726
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily oral 100 mg KH176 for 28 days
Trial: 28134225
Drug: LABA (long-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LABA (long-acting beta-agonist) such as indacaterol, vilanterol, or olodaterol used once a day.
Trial: 28134225
Drug: LAMA (long-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAMA (long-acting muscarinic antagonist) such as tiotropium, glycopyrronium, aclidinium, or umeclidinium.
Trial: 28134225
Drug: Combined preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined preparations of LAMA-LABA.
Trial: 28134225
Drug: MABA (muscarinic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MABA (muscarinic antagonist and β2 agonist).
Trial: 20939799
Drug: Fluocinolone acetonide
RxNorm normalized name: Fluocinolone Acetonide
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinolone acetonide intravitreal implant (Retisert)
Trial: 20939799
Drug: Fluocinolone acetonide
RxNorm normalized name: Fluocinolone Acetonide
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinolone acetonide intravitreal implant (Iluvien)
Trial: 20939799
Drug: Combination photocoagulation
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination photocoagulation and pharmacotherapy
Trial: 17595894
Drug: Digox 0.25
RxNorm normalized name: Digox 0.25 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digox 0.25 mg tablet from Pharlab Ind. Ltd., Brazil
Trial: 17595894
Drug: Digoxin 0.25
RxNorm normalized name: digoxin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin 0.25 mg tablet from Laboratório Glaxo SmithKline, Brazil
Trial: 2528440
Drug: Etodolac (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etodolac (600 mg/day)
Trial: 31730814
Drug: Anti-viral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-viral therapy
Trial: 28517974
Drug: DHA +
RxNorm normalized name: PNV-DHA + Docusate Softgel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA + aspirin therapy (2 g DHA + 81 mg aspirin daily)
Trial: 28517974
Drug: Placebo (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (placebo capsules)
Trial: 25867448
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (CBT and SST)
Trial: 22663759
Drug: Attendance education
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Attendance education during monthly visits at the center
Trial: 12686509
Drug: Duodenal acid
RxNorm normalized name: Sus scrofa duodenum preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duodenal acid infusion (0.1 N HCl)
Trial: 8678498
Drug: 5-FU (500-750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-FU (500-750 mg/body) and LV (30 mg/body) for 5 days
Trial: 8678498
Drug: 5-FU (500-750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-FU (500-750 mg/body) and LV (30 mg/body) plus cisplatin (10 mg/body)
Trial: 1872778
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose monophasic combined oral contraceptive
Trial: 1872778
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose danazol
Trial: 25140396
Drug: Rosuvastatin 10
RxNorm normalized name: rosuvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 10 mg/day (R10)
Trial: 25140396
Drug: Rosuvastatin 40
RxNorm normalized name: rosuvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 40 mg/day (R40)
Trial: 17661764
Drug: Octreotide (Sandostatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide (Sandostatin LAR 20 mg i.m.)
Trial: 15679243
Drug: Concomitant cisplatin-based
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concomitant cisplatin-based chemotherapy with radiotherapy
Trial: 15679243
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy (cisplatin-5FU) followed by local treatment
Trial: 10737578
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin injection in the internal anal sphincter on each side of the posterior midline (group I)